Surgical treatment of sacral chordoma: survival and prognostic factors

C. Ruosi, G. Colella, S. L. Di Donato, F. Granata, M. G. Di Salvatore, F. Fazioli

Research output: Contribution to journalArticle

Abstract

Introduction: Sacral chordoma is a rare low-to-intermediate grade malignant tumour. The mainstay of treatment is still surgery with en bloc and wide resection margins, which can grant the best chances of a long-term control or cure of this disease. The first aim of this paper is to collect data about survival, time to local recurrence and metastasis among patients affected by sacral chordoma and primarily treated with surgery. The second aim is to analyze the influence of level resection, tumor volume and surgical margins on local recurrence. Materials and methods: The study population was composed of 14 patients treated with sacral chordoma resection at the National Tumour Institute of Naples—Pascale (Italy) from January 2000 to June 2013. The median follow-up was 84 months (range 24–132 months). The follow-up was characterized by: standard radiographs, MRI, and a CT scan of the chest annually. Time to recurrence or metastasis was calculated from the date of resection to the date of diagnosis of first recurrence or metastasis. Results: Out of all the patients, six died (42.86 %) during the follow-up; 6 (42.86 %) had local recurrence; 4 (28.57 %) had metastasis. At univariate analysis wide surgical margins (R0) were associated with increased survival up to a local recurrence (OR = 0.0286; 95 % CI = 0.0014–0.5739; P = 0.026); the level of resection (OR = 3.33; 95 % CI = 0.3619–30.7025; P = 0.592) and tumour volume (P = 1) did not show a statistically significant correlation. Discussion: Based on our experience, we hope all patients to be treated by surgery, the only good standard treatment of this disease. The resection should result in margins as wide as possible. For these reasons, it is essential for this disease to be treated in highly specialized centres because only a complete surgery can offer a chance to care for these patients. Conclusions: Solid survival at long-term follow-up can be achieved by a surgical resection performed with wide margins.

Original languageEnglish
Pages (from-to)912-917
Number of pages6
JournalEuropean Spine Journal
Volume24
DOIs
Publication statusPublished - Nov 1 2015

    Fingerprint

Keywords

  • Prognostic factor
  • Sacral chordoma
  • Surgical resection
  • Survival

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Ruosi, C., Colella, G., Di Donato, S. L., Granata, F., Di Salvatore, M. G., & Fazioli, F. (2015). Surgical treatment of sacral chordoma: survival and prognostic factors. European Spine Journal, 24, 912-917. https://doi.org/10.1007/s00586-015-4276-4